9 studies found for:    15364185 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)
Conditions: Atherosclerotic Cardiovascular Disease;   Familial Hypercholesterolemia;   Diabetes
Intervention: Drug: ALN-PCSSC
2 Completed Melatonin in Smoke-induced Vascular Injury
Conditions: Smoking;   Vascular System Injuries
Interventions: Other: non-smoker oral placebo;   Drug: non-smoker oral melatonin;   Other: smoker oral placebo;   Drug: smoker oral melatonin
3 Not yet recruiting Self-screening of Cardiovascular Risk
Condition: Risk Factor, Cardiovascular
Interventions: Behavioral: CV-screening-1 plus personalized;   Behavioral: CV-screening-2 plus personalized;   Behavioral: CV-screening-1 plus standard;   Behavioral: CV-screening-2 plus standard
4 Recruiting Mood and Nutrition Interventions in Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome (PCOS)
Interventions: Behavioral: Cognitive Behavioral Therapy;   Behavioral: Nutrition Counseling
5 Recruiting Visualization of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention
Condition: Cardiovascular Diseases
Intervention: Behavioral: Information vs no information about carotid ultrasound results on asymptomatic atherosclerosis
6 Recruiting "Hjerteloeftet" ("HeartLift"). Interaction For Preventing Cardiovascular Disease
Condition: Cardiovascular Disease
Intervention: Behavioral: Intervention (INT1)
7 Completed Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
Condition: Myocardial Infarction
Interventions: Drug: FDC;   Drug: Separately drugs, simvastatin, aspirin and ramipril
8 Unknown  Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Drug: aged garlic extract;   Drug: Placebo
9 Completed Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity
Conditions: Obesity;   GHD
Intervention: Drug: Recombinant GH Saizen (Merck-Serono)

Indicates status has not been verified in more than two years